Patient-specific nanotherapy refers to the use of nanocarriers for precise drug delivery in treating liver diseases, thereby reducing nonspecific accumulation and minimizing adverse effects in normal cells [261]
Herniated discs affect roughly 2% of the general population at any given time, with the L4-L5 and L5-S1 levels accounting for approximately 95% of lumbar herniations
10.1155/2018/9185368 264 YuanP.YangT.MuJ.ZhaoJ.YangY.YanZ.et al
The recommended injection sites are the abdomen (at least 2 inches away from the belly button), the front of the thigh (middle third), and the back of the upper arm (if someone else can administer the injection for you)
Clinical outcomes The primary end points were the participant incidence of TEAEs, changes in laboratory safety tests, vital signs and 12-lead electrocardiograms
p 0.2) and there were no significant differences in brain GSH between sexes in the ACC ( p = 0.8) or DLPFC ( p = 0.5)